2022

August 23, 2022

Novo Holdings acquires The Ritedose Corporation and fully automated packaging lines increased to six

Continue reading

2021

August 23, 2022

Commercial launch of 503B Outsourcing Facility

Continue reading

Stability & Regulatory Support

January 24, 2020

ICH Stability program to support semipermeable conditions. Regulatory team supports project throughout regulatory lifecycle.

Continue reading

Analytical & Microbiology Support

January 24, 2020

Dedicated multidisciplinary team to support all aspects of development from method development, method validation, sterility & bioburden along with our robust microbiology lab.

Continue reading

Process Development & Technology Transfer

January 24, 2020

Development engineering teams lead all aspects of product development/transfers from the clinical study stage and manage projects throughout the development lifecycle, process validation & commercial launch.

Continue reading

2019

January 16, 2020

TRC registers with FDA as a 503B Outsourcing and Repackaging Facility

Continue reading

2018

January 16, 2020

Plant expansion of over 150,000 sq ft for packaging and distribution

Continue reading

2016

January 16, 2020

TRC obtains fourth ANDA and operating capacity reaches 2.1 billion units with 10 BFS machines, five fully automated packaging lines and one semi-automated packaging line

Continue reading

2013

January 16, 2020

EU compliant expansion Quality & Development Lab expansion

Continue reading

2012

January 16, 2020

TRC launches Ritedose Pharmaceuticals (RDP) and obtains third ANDA

Continue reading